Gene editing can also reinforce resistance to the suppressive tumor microenvironment by disrupting checkpoint regulators like PD-1, TIGIT, and TGF-β receptors, limiting tumor-mediated inhibition of NK cells. This evidence concerns the gene TIGIT and neoplasm.